Prelude Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $4,000 | $3,000 | $0 | $0 |
Gross Profit | 4,000 | 3,000 | -452 | -426 |
EBITDA | -33,342 | -33,971 | -36,712 | -33,917 |
EBIT | -33,831 | -34,376 | -37,164 | -34,343 |
Net Income | -28,731 | -32,271 | -34,740 | -31,431 |
Net Change In Cash | 4,000 | 3,000 | 0 | 0 |
Free Cash Flow | -20,797 | -27,359 | -23,416 | -32,080 |
Cash | 12,474 | 11,134 | 27,828 | 24,707 |
Basic Shares | 75,805 | 75,855 | 75,762 | 75,735 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,000 | $0 | $0 | $0 |
Gross Profit | 7,000 | -1,169 | -3,042 | -2,243 |
EBITDA | -139,714 | -131,108 | -122,216 | -112,820 |
EBIT | -132,277 | -123,540 | -113,735 | |
Net Income | -127,173 | -121,832 | -107,336 | -110,779 |
Net Change In Cash | 7,000 | 0 | 0 | 0 |
Free Cash Flow | -103,652 | -110,576 | -86,748 | -85,854 |
Cash | 12,474 | 25,291 | 30,605 | 31,828 |
Basic Shares | 75,805 | 60,357 | 47,371 | 47,602 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.37 |
2024-09-30 | -$0.43 |
2024-06-30 | -$0.46 |
2024-03-31 | -$0.42 |
